Effectiveness and Safety of Amlodipine in Newly Diagnosed Hypertensive Patients and in Previously Diagnosed Hypertensive Patients not Controlled with their Usual Treatment (NOTA Study).

Effectiveness and Safety of Amlodipine in Newly Diagnosed Hypertensive Patients and in Previously Diagnosed Hypertensive Patients not Controlled with their Usual Treatment (NOTA Study). Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Effectiveness and Safety of Amlodipine in Newly Diagnosed Hypertensive Patients and in Previously Diagnosed Hypertensive Patients not Controlled with their Usual Treatment (NOTA Study). Abstract Text:

Y ,R ,R ,A Gil, ,

OBJECTIVE: To evaluate the effectiveness and safety of amlodipine in two cohorts of hypertensive patients, one newly diagnosed and the other previously diagnosed but not controlled with drug therapy, and to assess the risk factors for the entire sample at the outset of the study. PATIENTS AND DESIGN: We designed a postmarketing, multicentre, open-label, prospective, observational surveillance study with a 6-month follow-up, which included hypertensive patients (systolic blood pressure [SBP] >/=140mm Hg and/or diastolic blood pressure [DBP] >/=90mm Hg) who attended specialised units and had either newly diagnosed or previously diagnosed pharmacologically uncontrolled arterial hypertension. RESULTS: Of the total of 1797 patients eligible for evaluation, 760 (42.3%) were newly and 1037 (57.7%) were previously diagnosed. Of these, 22.9% were classified as being in the high-risk and 43.2% in the very high-risk groups at the outset of the study (WHO-ISH [International Society of Hypertension]). On conclusion of the 6-month follow-up, 54.3% of newly diagnosed and 44.4% of previously treated patients had attained the BP therapy targets defined as SBP <140mm Hg and DBP <90mm Hg, representing a statistically significant difference (p < 0.0001). A total of 8% of patients experienced some adverse event during the course of the study, with this percentage being somewhat higher in the previously treated than in the newly diagnosed group (10.8% vs 5.1%, p < 0.0001). Only 0.3% experienced some severe adverse event, although in no case was this linked to the drug under evaluation. CONCLUSIONS: We conclude that amlodipine has shown itself to be an effective and safe drug for the control of hypertension, whether isolated or associated with other cardiovascular risk factors, both in patients without a previous diagnosis of arterial hypertension and in those previously diagnosed although not controlled under a prior treatment regimen.

Effectiveness and Safety of Amlodipine in Newly Diagnosed Hypertensive Patients and in Previously Diagnosed Hypertensive Patients not Controlled with their Usual Treatment (NOTA Study). Publishing Authors By Initials

Y ,R ,R ,A Gil, ,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Effectiveness and Safety of Amlodipine in Newly Diagnosed Hypertensive Patients and in Previously Diagnosed Hypertensive Patients not Controlled with their Usual Treatment (NOTA Study). Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Clinical drug investigation

VOLUME: 23

Page Numbers: 761-70

Journal Abbreviation:

ISSN: 1173-2563

DAY: 31

MONTH: 05

YEAR: 2003

Effectiveness and Safety of Amlodipine in Newly Diagnosed Hypertensive Patients and in Previously Diagnosed Hypertensive Patients not Controlled with their Usual Treatment (NOTA Study). Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9504817

Effectiveness and Safety of Amlodipine in Newly Diagnosed Hypertensive Patients and in Previously Diagnosed Hypertensive Patients not Controlled with their Usual Treatment (NOTA Study). Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Effectiveness and Safety of Amlodipine in Newly Diagnosed Hypertensive Patients and in Previously Diagnosed Hypertensive Patients not Controlled with their Usual Treatment (NOTA Study). Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Effectiveness and Safety of Amlodipine in Newly Diagnosed Hypertensive Patients and in Previously Diagnosed Hypertensive Patients not Controlled with their Usual Treatment (NOTA Study).

AFFILIATION: Faculty of Health Sciences, Rey Juan Carlos University, Madrid, Spain.

Country: New Zealand

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Clin Drug Investig

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Effectiveness and Safety of Amlodipine in Newly Diagnosed Hypertensive Patients and in Previously Diagnosed Hypertensive Patients not Controlled with their Usual Treatment NOTA Study Related Publications

• Activation of bile acid biosynthesis by the p38 mitogen-activated protein kinase (MAPK): hepatocyte nuclear factor-4alpha phosphorylation by the p38 MAPK is required for cholesterol 7alpha-hydroxylase expression.
• Alterations in plasma and tissue lipids associated with obesity and metabolic syndrome.
• Analysis of the Essential Oil from Helichrysum picardii.
• Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells.
• Development of a biodegradable bioadhesive containing urethane groups.
• Development of insulin resistance and its relation to diet in the obese child.
• Differences in fine-scale genetic structure and dispersal in Quercus ilex L. and Q. suber L.: consequences for regeneration of mediterranean open woods.
• Differential protein expression of murine macrophages upon interaction with Candida albicans.
• Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
• Effectiveness and Safety of Amlodipine in Newly Diagnosed Hypertensive Patients and in Previously Diagnosed Hypertensive Patients not Controlled with their Usual Treatment (NOTA Study).
• Experimental problems in Raman spectroscopy applied to pigment identification in mixtures.
• Extracellular fluid expansion during parenteral refeeding.
• Immobilization of drugs for glaucoma treatment.
• In vitro response to Candida albicans in cultures of whole human blood from young and aged donors.
• Influence of the chemical structure on mobility of PCB congeners in female and male sardine (Sardina pilchardus) from Portuguese coast.
• Oxidized nickel-titanium foams for bone reconstructions: chemical and mechanical characterization.
• Potential microbial risk factors related to soil amendments and irrigation water of potato crops.
• Potential of NMR spectroscopy for the study of human amniotic fluid.
• Proteomic analysis of detergent-resistant membranes from Candida albicans.
• Quantitation of free and glycosidically bound volatiles in and effect of glycosidase addition on three tomato varieties (Solanum lycopersicum L.).
• Reconstructing signal transduction pathways: challenges and opportunities.
• Report. Proteomics Education, an Important Challenge for the Scientific Community: Report on the Activities of the EuPA Education Committee.
• Ten-year trends in self-rated health among spanish adults with diabetes, 1993 2003.
• The Vietnamese Khin population harbors particular N-acetyltransferase 2 allele frequencies.
• The potential anticancer agent PK11195 induces apoptosis irrespective of p53 and ATM status in chronic lymphocytic leukemia cells.
• The presence of a caregiving relative implicated in the administration of antiretroviral drug administration improves virologic response.
• [Cytoimmunological changes in the bronchoalveolar lavage in asbestos exposure patients]
• [Self-consciousness, consciousness of the other and dementias]
• [Trends in effects of maximum temperatures on organic-cause mortality in Castile-La Mancha, Spain from 1975 to 2003]
• [Utility of amylase serum and urine activity in acute biliary pancreatitis treated with biliary sphincterotomy]